Long-Term Safety and Disease Control With Ruxolitinib Cream in Atopic Dermatitis: Results From Two Phase 3 Studies

Main Article Content

Kim Papp
Jacek Szepietowski
Leon Kircik
Darryl Toth
Lawrence Eichenfeld
Seth Forman
Michael Kuligowski
May Venturanza
Kang Sun
Eric Simpson


safety, ruxolitinib cream, atopic dermatitis




1. Langan SM, et al. Lancet. 2020;396(10247):345-360.

2. Bao L, et al. JAKSTAT.2013;2(3):e24137.

3. Oetjen LK, et al. Cell. 2017;171(1): 217-228.

4. Papp K, et al. J Am Acad Dermatol. 2021;85(4):863-872

Similar Articles

You may also start an advanced similarity search for this article.

Most read articles by the same author(s)

1 2 3 4 5 6 7 8 9 > >>